TYMS antibody
Quick Overview for TYMS antibody (ABIN7882469)
Target
See all TYMS AntibodiesReactivity
Host
Clonality
Conjugate
Application
Clone
-
-
Purpose
- Thymidylate Synthase Antibody
-
Purification
- Affinity purified
-
Immunogen
- A synthetic peptide specific to human Thymidylate Synthase / TYMS was used as the immunogen for the Thymidylate Synthase antibody.
-
Isotype
- IgG
-
-
-
-
Application Notes
- Optimal dilution of the Thymidylate Synthase antibody should be determined by the researcher.
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Buffer
- Antibody in PBS with 0.02 % sodium azide, 50 % glycerol and 0.4-0.5 mg/mL BSA
-
Preservative
- Sodium azide
-
Precaution of Use
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Storage
- -20 °C
-
Storage Comment
- Store the Thymidylate Synthase antibody at -20oC.
-
-
- TYMS (Thymidylate Synthetase (TYMS))
-
Alternative Name
- Thymidylate Synthase
-
Background
- Thymidylate synthase catalyzes the methylation of deoxyuridylate to deoxythymidylate using, 10-methylenetetrahydrofolate (methylene-THF) as a cofactor. This function maintains the dTMP (thymidine-5-prime monophosphate) pool critical for DNA replication and repair. The enzyme has been of interest as a target for cancer chemotherapeutic agents. It is considered to be the primary site of action for 5-fluorouracil, 5-fluoro-2-prime-deoxyuridine, and some folate analogs. Expression of this gene and that of a naturally occurring antisense transcript, mitochondrial enolase superfamily member 1, vary inversely when cell-growth progresses from late-log to plateau phase. Polymorphisms in this gene may be associated with etiology of neoplasia, including breast cancer, and response to chemotherapy. [RefSeq]
-
UniProt
- P04818
-
Pathways
- Mitotic G1-G1/S Phases
Target
-